Author:
Chen Li-Chia,Ashcroft Darren M.,Elliott Rachel A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy,General Medicine,Pharmacology (medical),Pharmacology
Reference26 articles.
1. Duthie T, Trueman P, Chancellor J, Diez L. Research into the use of health economics in decision making in the United Kingdom–Phase II. Is health economics ‘for good or evil’? Health Policy 1999;46(2):143–57.
2. National Institute for Clinical Excellence (NICE). Guide to the methods of technology appraisal. Reference N0515. London: National Institute for Clinical Excellence; 2004.
3. Commonwealth Department of Human Services and Health. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee including major submissions involving economic analysis. Canberra: Australian Government Publishing Services; 2002.
4. Ontario Ministry of Health. Ontario guidelines for economic analysis of pharmaceutical products. Ontario: Ministry of Health; 1994.
5. Johannesson M. Economic evaluation of drugs and its potential uses in policy making. Pharmacoeconomics 1995;8(3):190–8.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献